Successful administration of cytarabine in a 16-month-old girl with acute myelogenous leukemia and cytarabine syndrome

Ann Allergy Asthma Immunol. 2009 Feb;102(2):173-4. doi: 10.1016/S1081-1206(10)60254-2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects*
  • Cytarabine / therapeutic use*
  • Diphenhydramine / therapeutic use
  • Drug Hypersensitivity / drug therapy
  • Drug Hypersensitivity / prevention & control
  • Female
  • Histamine Antagonists / therapeutic use
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use*
  • Infant
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myeloid, Acute / drug therapy*
  • Methylprednisolone / therapeutic use
  • Premedication
  • Ranitidine / therapeutic use
  • Syndrome
  • Treatment Outcome

Substances

  • Histamine Antagonists
  • Immunosuppressive Agents
  • Cytarabine
  • Ranitidine
  • Diphenhydramine
  • Methylprednisolone